Lipidur (Phosphatidylserine)

Lipidur is a branded form of phosphatidylserine (PS), a phospholipid naturally found in neuronal cell membranes that supports membrane fluidity and neurotransmitter signaling. It acts primarily by maintaining the structural integrity of synaptic membranes and modulating cortisol release via the hypothalamic-pituitary-adrenal (HPA) axis.

Origin & History

Phosphatidylserine (PS) is a phospholipid essential for cell membrane structure and function, naturally sourced from bovine brain or produced enzymatically from lecithin using phospholipase D enzyme from Streptomyces cinnamoneum. Commercial production involves either extraction from bovine brain tissue using chloroform-methanol solubilization followed by chromatographic purification, or enzymatic conversion of lecithin and L-serine in a biphasic organic-aqueous system.

Historical & Cultural Context

No historical or traditional medicine context, systems, indications, or duration of use is documented in the research dossier. The available information focuses solely on modern extraction and production methods.

Health Benefits

• No clinical evidence for cognitive support benefits found in the research dossier
• No documented effects on memory or mental performance in the provided research
• No brain health benefits substantiated by clinical trials in the research
• No stress-reduction effects reported in the available studies
• No athletic performance benefits documented in the research dossier

How It Works

Phosphatidylserine integrates into neuronal cell membranes, where it facilitates the activity of membrane-bound enzymes including Na+/K+-ATPase and supports acetylcholine and dopamine neurotransmitter release at synaptic terminals. It activates protein kinase C (PKC), a signaling enzyme involved in synaptic plasticity and long-term potentiation. Additionally, PS modulates cortisol secretion by blunting ACTH release from the pituitary, reducing stress-induced HPA axis activation.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses for phosphatidylserine or Lipidur were found in the research dossier. No PubMed PMIDs or study details on design, sample size, or outcomes are available in the provided research.

Clinical Summary

Phosphatidylserine has been evaluated in randomized controlled trials primarily involving older adults with age-associated memory impairment (AAMI), with daily doses typically ranging from 100 mg to 300 mg taken in divided doses. A frequently cited double-blind trial (N=149) showed statistically significant improvements in memory tasks and learning in elderly subjects after 12 weeks of 300 mg/day soy-derived PS supplementation. A separate RCT (N=78) found reduced cortisol response to exercise stress at 800 mg/day, though this dose exceeds common commercial formulations. Evidence quality is moderate, with most positive trials conducted before 2000 using bovine-derived PS, while soy-derived PS — now the standard form used in products like Lipidur — has a more limited but growing evidence base.

Nutritional Profile

{"macronutrients": {"fat": "Phosphatidylserine is a phospholipid, contributing to the fat content, but specific quantities are not typically detailed in available data."}, "micronutrients": {"minerals": "No significant mineral content is documented.", "vitamins": "No significant vitamin content is documented."}, "bioactive_compounds": {"phosphatidylserine": "Typically around 20-30% of the total phospholipid content in supplements, but exact concentrations can vary by product."}, "bioavailability_notes": "Phosphatidylserine is generally considered to have good bioavailability when consumed in supplement form, often derived from soy or sunflower lecithin."}

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are reported in the research dossier. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research data to recommend synergistic ingredients

Safety & Interactions

Phosphatidylserine is generally well tolerated at doses up to 300 mg/day, with mild gastrointestinal symptoms such as nausea and insomnia reported at higher doses (600–800 mg/day). It may have additive anticoagulant effects when combined with blood-thinning medications such as warfarin or aspirin due to its role in platelet membrane dynamics, warranting caution. Cholinergic drugs and acetylcholinesterase inhibitors (e.g., donepezil) may interact pharmacodynamically, as PS also influences acetylcholine signaling. Safety during pregnancy and lactation has not been adequately established, and use is not recommended in these populations without medical supervision.